Rapid, census-tract-level risk intelligence delivered directly into your strategic planning workflow—with zero complex software onboarding or data science overhead.

• Prospective Chronic Disease Targeting: Pinpoint exact census tracts with heightened statistical risk for future onset of Diabetes, Coronary Heart Disease, Heart Failure, and Maternal Complications before clinical events occur.
• Impact Tier Stratification: Instant categorization of target geographies into High, Medium, and Low Impact Tiers to optimize preventive capital deployment.
• Performance-to-Risk Indexing (PRR): Advanced comparative indexing evaluating observed health outcomes against predicted SDoH baselines to expose hidden gaps and community resilience.
• Actionable Driver Mapping: Clear isolation of the primary 78 environmental levers driving outcome variance in each target tract.

When institutional reporting requirements demand custom modeling or executive alignment, our team operates as an extension of your leadership team.

• Custom Endpoint Modeling: Developing SDoH-driven predictive models for rare indications, specialty drug adoption, or proprietary clinical endpoints.
• Cross-Market Portfolio Assessments: Conducting multi-market comparative analyses for health system expansions, service line placements, or pharma territory alignment.
• Executive Dossier Development: Translating statistical findings into board-ready presentations, CHIP investment plans, or payer value dossiers.